These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4560824)

  • 1. Clinical evaluation of oxprenolol in angina pectoris.
    Sandler G; Pistevos A
    Br Heart J; 1972 Aug; 34(8):847-50. PubMed ID: 4560824
    [No Abstract]   [Full Text] [Related]  

  • 2. A total of 254 cases of angina pectoris treated with oxprenolol in hospital practice--a monitored release study.
    Forrest WA
    Br J Clin Pract; 1972 May; 26(5):217-22. PubMed ID: 4625606
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of oxprenolol slow release and osmotic release by exercise testing and ambulatory electrocardiographic monitoring in patients with chronic stable angina pectoris.
    Bowles MJ; Khurmi NS; O'Hara MJ; Raftery EB
    Eur J Clin Pharmacol; 1987; 32(2):127-33. PubMed ID: 3556193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Slow release oxprenolol in angina pectoris [proceedings].
    Goldstraw PW; Taylor SH; Thadani U; Watt SJ
    Br J Clin Pharmacol; 1977 Jun; 4(3):387P. PubMed ID: 332219
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of clinical effects of propranolol (Inderal) with once daily slow-release oxprenolol (Slow Trasicor) in angina pectoris.
    Majid PA; de Feijter PJ; Wardeh R; van der Wall EE; Roos JP
    J Int Med Res; 1979; 7(3):194-200. PubMed ID: 378729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Multi-centric study of angina pectoris under oxprenolol treatment combined with nitrates in the Trivento region].
    Dalla Volta S; D'Amelio G
    Minerva Cardioangiol; 1980; 28(7-8):475-80. PubMed ID: 7005710
    [No Abstract]   [Full Text] [Related]  

  • 7. Experience with a sustained-release formulation of oxprenolol in the management of angina pectoris in hospital out-patient departments.
    Forrest WA
    Curr Med Res Opin; 1978; 5(9):669-74. PubMed ID: 104825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxoprenolol in angina pectoris.
    Lewis BS; Bakst A; Gotsman MS
    S Afr Med J; 1972 Aug; 46(34):1209-14. PubMed ID: 5056770
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative trial of perhexiline maleate and oxprenolol in patients with angina pectoris.
    Pilcher J
    Postgrad Med J; 1978 Oct; 54(636):663-7. PubMed ID: 368744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical effect of oxprenolol in angina pectoris: comparison with a placebo and propranolol by double blind assay].
    Murakami M; Murakami E; Takekoshi J; Hayase S; Shintani H
    Nihon Rinsho; 1973 Apr; 31(4):913-22. PubMed ID: 4580401
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of the immediate effects of five beta-adrenoreceptor-blocking drugs with different ancillary properties in angina pectoris.
    Thadani U; Davidson C; Singleton W; Taylor SH
    N Engl J Med; 1979 Apr; 300(14):750-5. PubMed ID: 581782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Controlled clinical trial of 5 antianginal treatments].
    Scardi S; Borgioni L; Alberti E; Palmieri M; Passarelli A; Ruggeri G; Zappalá A; Baroni F; Camerini F
    G Ital Cardiol; 1978 Jun; 8(6):587-600. PubMed ID: 352779
    [No Abstract]   [Full Text] [Related]  

  • 13. A double-blind clinical trial in angina pectoris. A comparison between oxprenolol, practolol and placebo.
    Forrest WA
    Br J Clin Pract; 1975 Dec; 29(12):343-6. PubMed ID: 764841
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of angina pectoris with oxprenolol. Its evaluation with ergometric tests].
    Tormo Alfonso V; Velasco Rami JA; Serra Sister E; Mora Marti F
    Rev Clin Esp; 1978 Sep; 150(6):361-5. PubMed ID: 725180
    [No Abstract]   [Full Text] [Related]  

  • 15. [Slow-Trasicor in the treatment of angina pectoris].
    Giec L; Trusz-Gluza M; Hübner D; Olwiński M
    Wiad Lek; 1984 Sep; 37(18):1401-6. PubMed ID: 6397916
    [No Abstract]   [Full Text] [Related]  

  • 16. Oxprenolol in angina pectoris [proceedings].
    Taylor SH; Thadani U
    Br J Pharmacol; 1976 Nov; 58(3):412P. PubMed ID: 990603
    [No Abstract]   [Full Text] [Related]  

  • 17. Objective and subjective parameters in angina pectoris (effect of beta-receptor blockade).
    Shah SJ; Billimoria AR; Anand MP; Haveliwala HK; Vibhakar BB
    Indian Heart J; 1972 Oct; 24(4):337-41. PubMed ID: 4632392
    [No Abstract]   [Full Text] [Related]  

  • 18. [Study of the effects of oxprenolol on pain and on electrocardiographic changes in patients with ischemic heart disease].
    Contino A
    G Clin Med; 1979 May; 60(5):402-8. PubMed ID: 488590
    [No Abstract]   [Full Text] [Related]  

  • 19. Beta-adrenergic receptor blocking drugs in angina pectoris.
    Prichard BN
    Drugs; 1974; 7(1):55-84. PubMed ID: 4151695
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical study of delayed-action oxprenolol in the treatment of angina pectoris. Apropos of 21 cases].
    Fournier D
    Lille Med; 1981; 26(1-2):62-4. PubMed ID: 7206997
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.